Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study
Clinical Research in Cardiology · 10.08.2026
DOI: 10.1007/s00392-026-02995-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 10.08.2026. Verfasst von Sergio Buccheri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca Mölndal, Uppsala University.
Abstract (Originalsprache)
Aim
In patients with chronic coronary syndrome, risk factors for ischaemic events and bleeding tend to overlap. However, the combined effects of these factors have scarcely been studied in contemporary real-world settings.
Methods
All patients in Sweden undergoing elective PCI for chronic coronary syndrome between 2006 and 2014 enrolled in the SWEDEHEART registry were included. Six risk factors (age ≥ 65 years, chronic kidney disease, diabetes, multivessel disease (MVD), prior bleeding, and prior acute myocardial infarction (AMI)) were assessed in relation to the risk of ischaemic (cardiovascular death/AMI/stroke) and major bleeding events.
Results
We studied 24,051 patients, of whom 59% had ≥ 2 risk factors. During a median follow-up of 3.7 years, 3604 (15.0%) patients experienced ischaemic events and 2076 (8.6%) experienced major bleeding events . Higher numbers of risk factors were associated with a stepwise increase in the incidence of both ischaemic and bleeding events, being more substantial for ischaemic compared to bleeding events. In adjusted Cox models, prior bleeding was of less importance as compared to other risk factors for new ischaemic events. For bleeding events, diabetes, MVD, and prior AMI had limited relevance compared with other risk factors. When excluding patients with prior major bleeding, the increase in ischaemic risk with an increasing number of risk factors was more pronounced, whereas the increase in bleeding incidence was attenuated. .
Conclusions
Among patients with angiographically confirmed chronic coronary syndrome, the majority had two or more established risk factors. An increasing number of risk factors was associated with a higher rate of ischaemic and bleeding events, being more substantial for ischaemic compared to bleeding events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden.
- Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
- Medical Department, AstraZeneca Nordic, Oslo, Norway.
- Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden. kasper.andersen@medsci.uu.se.
- Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. kasper.andersen@medsci.uu.se.
Förderung
- AstraZeneca Mölndal
- Uppsala University
Zitieren
APA
Buccheri, S., Sarno, G., Hasvold, L. P., Renlund, H., James, S., & Andersen, K. (2026). Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-026-02995-3
Vancouver
Buccheri S, Sarno G, Hasvold LP, Renlund H, James S, Andersen K. Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-026-02995-3
BibTeX
@article{Buccheri2026,
author = {Buccheri, Sergio and Sarno, Giovanna and Hasvold, Lars Pål and Renlund, Henrik and James, Stefan and Andersen, Kasper},
title = {Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study},
journal = {Clinical Research in Cardiology},
year = {2026},
doi = {10.1007/s00392-026-02995-3}
}
EUVIMED